Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences

Joo Hyun Oh ,  Dae Won Jun

Clinical and Molecular Hepatology

2024 .04

Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia

Hi ,  oyuki Suzuki ,  Tsubasa Tsutsumi 외 3명

Clinical and Molecular Hepatology

2024 .07

Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population

Oh Joo Hyun ,  Jun Dae Won

Gut and Liver

2024 .03

Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study

Michihi ,  o Iwaki ,  Hideki Fujii 외 42명

Clinical and Molecular Hepatology

2024 .04

Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression

Sumin Oh ,  Yang-Hyun Baek ,  Sungju Jung 외 19명

Clinical and Molecular Hepatology

2024 .04

The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective

Ca ,  los Jose Pi ,  ola 외 1명

Clinical and Molecular Hepatology

2024 .04

Diverse Functions of Macrophages in Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Inflammation and Metabolism

Jun Hee Jang ,  Jin Hyun Sung ,  Jin Young Huh

Immune Network

2025 .02

Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms

Shaghayegh Khanmohammadi ,  Mohammad Shafi Kuchay

Journal of Obesity & Metabolic Syndrome

2024 .06

Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations

Xinyi Lu ,  Rui Yang ,  Yu Chen 외 1명

Clinical and Molecular Hepatology

2024 .07

Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study

Seogsong Jeong ,  Yun Hwan Oh ,  Joseph C Ahn 외 13명

Clinical and Molecular Hepatology

2024 .07

Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease

Tsubasa Tsutsumi ,  Dan Nakano ,  Machiko Kawaguchi 외 3명

Clinical and Molecular Hepatology

2024 .04

Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD

Shuhei Fukunaga ,  Michita Mukasa ,  Dan Nakano 외 2명

Clinical and Molecular Hepatology

2024 .01

A New Korean Nomenclature for Steatotic Liver Disease

The Ko ,  ean Association fo ,  the Study of the Live

Gut and Liver

2024 .09

Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease

Yiyuan Zheng ,  Lina Zhao ,  Zhekun Xiong 외 11명

Clinical and Molecular Hepatology

2024 .07

Human epididymis protein 4 accelerates tumor metastasis and metaplasia in the tumor microenvironment

Buhyun Lee ,  Yejin Cho ,  Haengdueng Jeong 외 9명

한국실험동물학회 학술발표대회 논문집

2017 .08

Human epididymis protein 4 accelerates tumor metastasis and metaplasia in the tumor microenvironment

Buhyun Lee ,  Kwanghui Kim ,  Yejin Cho 외 11명

한국실험동물학회 학술발표대회 논문집

2019 .01

Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”

Eileen L. Yoon ,  Dae Won Jun

Clinical and Molecular Hepatology

2024 .01

Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”

Kuo Chao Yew ,  Sunny H. Wong ,  Vincent Wai-Sun Wong 외 1명

Clinical and Molecular Hepatology

2024 .01

No More NAFLD: The Term Is Now MASLD

배지철

Endocrinology and Metabolism

2024 .02

Loss of human epididymis protein 4 inhibits oxyntic atrophyinduced spasmolytic polypeptide expressing metaplasia

Buhyun Lee ,  Sungsook Yu ,  Kwang Hui Kim 외 7명

한국실험동물학회 학술발표대회 논문집

2018 .01